Blog

Abhishek Garg: Circadian rhythm based regulation of CD8+T cell function dictates the efficacy of cancer immunotherapy

Abhishek Garg/LinkedIn

May 11, 2024, 01:27

Abhishek Garg: Circadian rhythm based regulation of CD8+T cell function dictates the efficacy of cancer immunotherapy

Abhishek Garg, Head of Laboratory of Cell Stress and Immunity (CSI) Lab at KU Leuven, shared on their LinkedIn:

”New Research alert!

Happy that our lab collaborated on this exciting research from Christoph Scheiermann lab that shows that circadian rhythm based regulation of CD8+T cell infiltration and function dictates the efficacy of cancer immunotherapy!

We saw that the ‘correct’ time-of-day genetic signature (i.e., time stamp) associated with favourable immunotherapy-response in melanoma patients at singlecell omics level!

Congratulations to Christoph Scheiermann’s team and all the collaborators: Ho Ping-Chih, Stefan Naulaerts, Stephanie Hugues, Camilla Jandus and several others!”

Abhishek Garg

Source: Abhishek Garg/LinkedIn

Abhishek Garg Camilla Jandus cancer cancer immunotherapy Cancer research Christoph Scheiermann Ho Ping-Chih KU Leuven melanoma patients OncoDaily Oncology Stefan Naulaerts Stephanie Hugues

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage